Back to directory
Country
United Kingdom
City
London
Founded
2019
Headcount
51-200
England
Description
Alchemab is a clinical-stage biotechnology company uncovering protective antibodies from disease-resilient individuals to discover and develop novel therapeutics.
Funding history
No funding rounds tracked.
Founders
-
Jane Osbourn
Co-Founder & CEO